Suicidal Behavior and Severe Neuropsychiatric Disorders Following Glucocorticoid Therapy in Primary Care
- 1 May 2012
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 169 (5) , 491-497
Abstract
An epidemiological study of British general practice patients who received oral glucocorticoids showed that patients who received these drugs were seven times as likely to attempt suicide as were patients with the same illness who did not receive steroids. The increase was most prominent in younger people. Mania and delirium were also significantly more common, particularly in older men. Neuropsychiatric effects were more common in patients receiving higher doses and those with previous mental disorders. Objective:The incidence and the risk of suicidal behaviors and severe neuropsychiatric disorders in people treated with systemic glucocorticoids are poorly known. The authors assessed the incidence rates of depression, mania, delirium, panic disorder, and suicidal behaviors in patients treated with glucocorticoids in primary care settings and the risk factors for developing these outcomes. Method:Data were obtained for all adult patients registered between 1990 and 2008 at U.K. general practices contributing to The Health Improvement Network (THIN) primary care database. The incidence rates for the outcomes of interest were assessed in patients who received prescriptions for oral glucocorticoids and compared with those in patients who did not receive such prescriptions. The predictors of these outcomes in exposed patients were ascertained using Cox proportional hazards models. Results:Overall, 786,868 courses of oral glucocorticoids were prescribed for 372,696 patients. The authors identified 109 incident...Keywords
This publication has 34 references indexed in Scilit:
- Creating medical and drug code lists to identify cases in primary care databasesPharmacoepidemiology and Drug Safety, 2009
- The importance of defining periods of complete mortality reporting for research using automated data from primary carePharmacoepidemiology and Drug Safety, 2008
- Acute psychosis in systemic lupus erythematosusRheumatology International, 2007
- Validation studies of the health improvement network (THIN) database for pharmacoepidemiology researchPharmacoepidemiology and Drug Safety, 2006
- Population‐based assessment of adverse events associated with long‐term glucocorticoid useArthritis Care & Research, 2006
- The relationship between time since registration and measured incidence rates in the General Practice Research DatabasePharmacoepidemiology and Drug Safety, 2005
- The VAMP research multi-purpose database in the U.K.Journal of Clinical Epidemiology, 1995
- Depression, somatization and steroid use in chronic obstructive pulmonary diseaseInternational Journal of Nursing Studies, 1989
- Steroid-induced psychiatric syndromesJournal of Affective Disorders, 1983
- Acute adverse reactions to prednisone in relation to dosageClinical Pharmacology & Therapeutics, 1972